Booz Allen Commercial delivers advanced cyber defenses to the Fortune 500 and Global 2000. We are technical practitioners and cyber-focused management consultants with unparalleled experience – we know how cyber-attacks happen and how to defend against them.
Our strategy and technology consultants have empowered our international clients with the knowledge and experience they need to build their own local resources and capabilities.
In facing challenges of modernization, our Middle East and North Africa clients have complex requirements that benefit from our proven experience in guiding major programs and projects for governments and private-sector organizations. The services we offer in UAE, Qatar, Egypt, Turkey, Kuwait, Morocco, Jordan, and other regional countries build on our consulting legacy.
Our clients call upon us to work on their hardest problems—delivering effective health care, protecting warfighters and their families, keeping our national infrastructure secure, bringing into focus the traditional boundaries between consumer products and manufacturing as those boundaries blur.
Booz Allen was founded on the notion that we could help companies succeed by bringing them expert, candid advice and an outside perspective on their business. The analysis and perspective generated by that talent can be found in the case studies and thought leadership produced by our people.
Explore our featured teams and missions. Search openings and find out how you can support our meaningful missions.
Continue your mission with us. Get advice from our recruiting team, and browse our FAQs.
Seeking an internship or entry-level position? Learn about the impact you can make on our team.
Find out more about our application process, explore our benefits, and review our FAQs.
Learn more about Booz Allen's diverse culture and environment of inclusion that fosters respect and opportunity for all employees.
Our 26,300 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
Booz Allen takes pride in a culture that encourages and rewards the many dimensions of leadership—innovative thinking, active collaboration, and personal service. We’re particularly proud of the diversity of our Leadership Team and Board of Directors, among the most diverse in corporate America today.
Vast amounts of data are becoming available for precision medicine, giving us the potential to make quantum leaps in our understanding of disease and how to treat it. But so far, we’ve had only a limited ability to use all this big data—much of it is scattered in countless isolated databases that have been difficult to bring together to get the big picture.
That’s changing. A new approach, developed by Booz Allen, is now making it possible to integrate a virtually unlimited amount of precision medicine data—and put it directly into the hands of researchers and other users.
“We need to let the data talk to us, so to speak. Conventional databases don’t do this well. ”
The advent of precision medicine marks the first time that the life sciences have truly entered the realm of big data. While other sciences, like meteorology and astronomy, have used big data for some time, it’s now precision medicine’s turn. We’re gaining access to an ever-growing tsunami of information, including genomic and other biospecimen-derived data, survey and demographic data, clinical and insurance-claims data, mobile and implant data—the list goes on.
Alan Kay, the pioneering computer scientist, has said that big data is really about “big meaning.” And if we are to realize the promise of precision medicine, we must be able to find that big meaning. Yet with traditional computing methods, there are major obstacles at every turn.
For example, a large portion of the data essential to precision medicine is locked up in conventional relational databases, in a profusion of formats. These databases typically were built to achieve specific purposes, or answer narrow types of questions, and cannot easily be integrated. As a result, only a relatively small amount of data can be brought together to solve a precision medicine problem.
For over two millennia we’ve defined access to healthcare by the in-person visit – going to see your doctor in an office. Our chief medical officer, Dr. Kevin Vigilante, explains how mobile technologies are changing that prevailing definition and impacting the medical community.
A second problem is that with relational databases, we have to know in advance the kinds of answers we expect to find. Researchers must first pose hypotheses about what the data might say, and then custom-build the databases to test the hypotheses. Yet an essential part of precision medicine is going beyond what we know—or think we know—by finding the kinds of hidden correlations and patterns that reveal the “unknown unknowns.”
We need to let the data talk to us, so to speak. Conventional databases don’t do this well.
In addition, much of the data we might use for precision medicine is “unstructured,” and cannot easily be formatted for conventional relational databases. Examples include images and text, such as doctors’ and nurses’ notes, and social media posts. Without these data sources, precision medicine can progress only to a certain point, and no further.
Conventional methods are also of limited help in overcoming one of the greatest obstacles to precision medicine, and that’s data sharing. The puzzles of precision medicine cannot be solved by a single government agency, life sciences company, or university. It requires what might be called a “megacommunity,” with all of government, business, and society pooling their data—and often their expertise—in a collaborative effort.
And yet traditional approaches to data cannot provide the necessary security and privacy protections that each stakeholder needs. Once again, precision medicine hits a brick wall.
Still another challenge is that with conventional methods, researchers without specialized training in IT don’t have direct access to the data. They must go through data scientists and other IT specialists in a laborious process to ask questions and get back answers. But with the explosion of data and analytics in virtually every corner of society, these IT experts are in high demand and short supply. There are simply not enough of them available to help researchers explore many of the most promising avenues of precision medicine.
The ultimate problem is that current computing approaches weren’t built for big data—they were developed when data was “smaller” and more manageable. The traditional methods worked well for many years, but they are not up to the task of addressing big-data challenges like precision medicine.